Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03325465
Title Neoadjuvant Pembrolizumab + Epacadostat Prior to Curative Surgical Care for Squamous Cell Carcinoma of the Head and Neck
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Chicago
Indications

head and neck squamous cell carcinoma

Therapies

Epacadostat + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.